|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-1-29
|
|
pubmed:abstractText |
Two consecutive randomized trials were run at our institution using the bioreductive alkylating agent mitomycin as an adjunct to radiation therapy in an effort to improve outcome in patients with squamous cell carcinoma of the head and neck.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
268-76
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8996152-Adult,
pubmed-meshheading:8996152-Aged,
pubmed-meshheading:8996152-Aged, 80 and over,
pubmed-meshheading:8996152-Antibiotics, Antineoplastic,
pubmed-meshheading:8996152-Carcinoma, Squamous Cell,
pubmed-meshheading:8996152-Chemotherapy, Adjuvant,
pubmed-meshheading:8996152-Dicumarol,
pubmed-meshheading:8996152-Enzyme Inhibitors,
pubmed-meshheading:8996152-Female,
pubmed-meshheading:8996152-Head and Neck Neoplasms,
pubmed-meshheading:8996152-Humans,
pubmed-meshheading:8996152-Male,
pubmed-meshheading:8996152-Middle Aged,
pubmed-meshheading:8996152-Mitomycins
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.
|
|
pubmed:affiliation |
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520-8040, USA. bruce.haffty@yale.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
